Original Research

Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines

Xin P, Li C, Zheng Y, Peng Q, Xiao H, Huang Y, Zhu X

Drug Design, Development and Therapy 2017, 11:1115-1126

Published Date: 3 April 2017